The Current Status and Proposals for the Implementation of Decentralized Clinical Trials (DCT) in Our Country from the Perspective of Service Providers

Abstract

This paper focused on the upcoming progression and challenges associated with Decentralized Clinical Trials (DCT) in Japan. It presents a comprehensive analysis of both the international and domestic states of DCTs, and offers strategic recommendations for their promotion and development within Japan’s clinical trial framework. The discussion includes patient-centric strategies, the importance of data integration, and expanding opportunities for subject participation. An examination of how DCTs can streamline clinical trials and enhance patient healthcare is also provided, indicating a significant role for DCTs in improving the clinical trial ecosystem in Japan.